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evoking microglia activation and neuronal
apoptosis
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Abstract
Background: Neuroinflammation plays a key role in the occurrence and development of postoperative cognitive
dysfunction (POCD). Microglia, the resident immune cells in the brain, has been increasingly recognized to
contribute to neuroinflammation. Although brain mast cells (MCs) are the “first responder” in the brain injury rather
than microglia, little is known about the functional aspects of MCs-microglia interactions.
Methods: Male Sprague-Dawley (SD) rats were injected intracerebroventricular with MC stabilizer Cromolyn
(100 μg/μl), MC stimulator C48/80 (1 μg/μl), or sterile saline 30 min before open tibial fracture surgery, and the
levels of neuroinflammation and memory dysfunction were tested 1 and 3 days after surgery. In addition, the effect
of activated MCs on microglia and neurons was determined in vitro.
Results: Tibial fracture surgery induced MCs degranulation, microglia activation, and inflammatory factors
production, which initiated the acute brain inflammatory response and neuronal death and exhibited cognitive
deficit. Site-directed preinjection of the “MCs stabilizer” disodium cromoglycate (Cromolyn) inhibited this effect,
including decrease of inflammatory cytokines, reduced MCs degranulation, microglia activation, neuronal death, and
improved cognitive function 24 h after the surgery. In vitro study, we found that the conditioned medium from
lipopolysaccharide (LPS)-stimulated mast cells line (P815) could induce primary microglia activation through
mitogen-activated protein kinase (MAPK) pathway signaling and subsequent production of tumor necrosis factor-α
(TNF-α) and interleukin-6 (IL-6). In addition, the activated P815 could directly induce neuronal apoptosis and
synapse injury with microglia independently. Cromolyn could inhibit P815 activation following improved microglia
activation and neuronal loss.
Conclusions: These results implicate that activated MCs could trigger microglia activation and neuronal damage,
resulting in central nervous system (CNS) inflammation, and communications of MCs with microglia and neuron
could constitute a new and unique therapeutic target for CNS immune inflammation-related diseases.
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Background
Postoperative cognitive dysfunction (POCD), commonly
observed in elderly patients, is characterized by impaired
concentration, memory, and learning following surgery.
POCD may be persistent over long durations of time or
even progress into serious central nervous system dis-
eases [1]. However, the pathophysiological mechanisms
underlying POCD still remain unclear, and no disease-
modifying or prophylactic therapies are currently avail-
able. Hence, unraveling the fundamental neuropathogen-
esis of POCD is an important challenge. Several studies
have demonstrated that neuroinflammation caused by
surgery is involved in the development of POCD [2, 3].
The initiation and propagation of neuroinflammation
appear to rely very much on the interaction between
microglia, immune cells, and neurons, with the
microglia-immune cell connection being poorly explored
thus far.
Microglia, the resident immune cells in the brain, play
an important role in both initiation of protective im-
mune responses and development of invasive inflamma-
tion during CNS disorders [4–7]. Increasing evidence
has defined activated microglia as an important response
of neuroinflammation [8]. When subjected to abnormal
stimulation, microglia become gradually activated and
produce numerous inflammatory mediators that may
cause neuronal damage, starting a vicious cycle [9]. As
such, inhibition of the exaggerated inflammatory re-
sponse mediated by activated microglia cells may help to
attenuate the severity of neurodegenerative diseases.
Although it is widely recognized that microglia activa-
tion contributes to neuroinflammation, proinflammatory
signals released from other nonneuronal cells of immune
origin like mast cells (MCs) are also critical players.
MCs, best known for their role in allergic inflammation,
also reside in the CNS, where they are often found along
the blood vessels and leptomeninges [10, 11]. Under
various types of stress, MCs serve as important sources
of several mediators, including proteases and vasoactive
amines such as GnRH [12], tryptase, and histamine [13],
which have been reported to induce microglia activation
and subsequent cytokine secretion in our previous stud-
ies [14, 15]. These inflammatory mediators released by
MCs participate in several neuroinflammatory diseases
[16]. Furthermore, meningeal MCs can recruit neutro-
phils and activated T cells to enter the brain by disrupt-
ing the blood-brain barrier [17]. Several molecular
mechanisms for potential interactions between MCs and
microglia have been determined in vitro [18]. However,
the exact effect of MCs on microglia is still unclear.
Given this background, we hypothesized that brain MCs,
the first responders in the CNS after surgery, are respon-
sible for inducing neuroinflammation and microglia acti-
vation, which may then cause cognitive dysfunction.
Methods
Animals
All experimental procedures involving animals were ap-
proved by IACUC (Institutional Animal Care and Use
Committee of Nanjing Medical University). Male
Sprague-Dawley rats weighted 200–250 g were used in
this experiment procedure (n = 84). All rats were housed
in groups of five animals per cage under specific
pathogen-free conditions (ambient temperature, 22.0 ±
1.0 °C; humidity, 40 %) during breeding and the experi-
ments. Food and water were available ad libitum. The
experiments were approved by the Nanjing Medical Uni-
versity Animal Care and Use Committee.
In vivo studies
Surgery and drug administration
The rats were randomly allocated to seven groups
(groups A–G) with 12 rats in each group and investiga-
tors were blinded to the experimental treatment. Rats of
group C and F were pretreated with MC stabilizer Cro-
molyn (100 μg/μl); groups D and G were pretreated with
MC stimulator C48/80 (1 μg/μl); groups B and E were
pretreated with sterile saline via intracerebroventricular
injection (ICV) for 30 min after anesthesia and analgesia,
while rats of group A was pretreated with sterile saline
under conscious state. After 30 min, rats of groups E–G
were treated with open tibial fracture surgery.
Following anesthesia, rats were placed in the stereo-
taxic apparatus (Stoelting Instruments, USA). Referring
to the atlas of Paxinos and Watson (1982), guide cannu-
las (Plastic One) were inserted into the lateral ventricle
(coordinates of 0.8 mm posterior, 1.5 mm lateral, and
3.7 mm ventral to the bregma) and secured to the skull
with dental cement. The animals were allowed to re-
cover in the animal facility for 14 days before use. Ani-
mals were handled daily to check the guide cannula and
to familiarize them with the investigators. To investigate
the exactly interactions between MC and microglia, we
administered 2 μl of 1 μg/μl C48/80 (2.5 μg), 2 μl of
200 μg/μl Cromolyn, or 2 μl sterile saline ICV, respect-
ively, 30 min before surgery.
Surgical animals underwent an open tibia fracture of
the left hind paw with an intramedullary fixation under
isoflurane anesthesia (2.1 % inspired concentration in 0.3
FiO2) as previously described [19]. Under full aseptic
conditions, the left hind limb of surgical animals was
meticulously shaved and disinfected with povidone iod-
ine. Briefly, a middle incision was performed on the left
hind paw followed by the insertion of a 20-G pin in the
intramedullary canal; the periosteum was then stripped
and osteotomy was performed. After producing the frac-
ture, the wound was irrigated and the skin was sutured
with 8/0 Prolene sutures. Temperature was monitored
and maintained optimal with a warming pad throughout
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the surgical process. Analgesia (0.1 mg/kg buprenor-
phine) was given subcutaneously after anesthetic induc-
tion and before skin incision. Rats of group B were
exposed to isoflurane anesthesia (2.1 % isoflurane in 0.3
FiO2) for 20 min in a temperature-controlled anesthetic
chamber, shaved and received buprenorphine as de-
scribed above only.
MCs staining and counting
Slides were stained in 0.05 % toluidine blue for hippo-
campus sections. A 1 % stock solution in 70 % ethanol
was dissolved in 0.5 % NaCl solution (pH 2.2–2.3), and
the slides were immersed 30 min in the above concen-
tration. They were then washed twice in distilled water,
dehydrated in a series of increasing concentrations of
ethanol, followed by placement in butyl acetate ester.
Samples were coverslipped using Eukitt® mounting
medium and were allowed to dry overnight.
MC counting was always performed in a blinded fash-
ion by an experimenter that was unaware of the sample
identity. Criteria for degranulation included loss of pur-
ple staining, fuzzy appearance, distorted shape, or mul-
tiple granules visible in the vicinity of the cell. The
entire surface area of the area CA1 of the hippocampus
was scanned manually using a light microscope at ×200
magnification and MCs were calculated with the help of
the Cell D software (Olympus).
In addition, immunohistochemistry was used to stain
MCs with mast cell tryptase monoclonal antibody as
follows.
Microglia staining
In physical condition, most of microglia cells stay in a
resting status, presented with obviously branch. Once
been activated, microglia cells will become amoeboid,
which had larger cell body, and poorly ramified short
and thick processes. Immunohistochemistry was used to
stain microglia cells with Iba1 polyclonal antibody as
follows.
Immunohistochemistry
Rats were anesthetized by 5 % chloral hydrate (0.8 ml/
100 g) and perfused first with 0.9 % saline and then with
cold 4 % paraformaldehyde (0.1 M phosphate buffer,
pH 7.4). The cerebral tissues were harvested, fixed with
4 % paraformaldehyde at 4 °C for 24 h. Brain sections
(10-μm-thick) were prepared and immunohistochemistry
was processed as follows. Endogenous peroxidase activ-
ity was blocked with 3 % H2O2 in PBS solution for
10 min. After incubation for 1 h in 10 % bovine serum
albumin with 0.3 % Triton X-100 in 0.01 M phosphate
buffer saline, the sections were then incubated with the
mast cell tryptase monoclonal antibody (1:100; Abcam;
USA), Iba1 polyclonal antibody (1:200; Wako; Japan),
and caspase-3 monoclonal antibody (1:100; CST, USA)
at 4 °C overnight and then incubated with secondary
antibody for 2 h. Positive cells were visualized by adding
DAB to the sections. For quantification [20], the studied
tissue sections were selected with a 150-μm interval ac-
cording to anatomical landmarks corresponding to
bregma from bregma −2.8 to −3.8 mm of the rat brain
(Paxinos and Watson, 1996). For each animal, 15 photo-
graphs from the CA1 area of three hippocampus sec-
tions and 15 photographs from the CA3 area of three
hippocampus sections were captured using Leika 2500
(Leica Microsystems, Wetzlar, Germany) at ×200 magni-
fication. The number of positive cells per photograph
(0.74-mm2 frame) was obtained by using NIH Image J
software (Bethesda, MD, USA), averaged, and converted
to cells per square millimeter. Positive cell counting was
performed in a blinded fashion by an experimenter that
was unaware of the sample identity.
Behavioral tests
Trace fear conditioning (TFC)
TFC is used to assess hippocampal-dependent memory
in rodents as previously described [20–22]. Rats were
trained to associate an environment (context) with a
conditional stimulus (tone) and an unconditional stimu-
lus (foot shock). The training consisted of placing the rat
in the conditioning chamber and allowing exploration of
the context for 100 s. Next, an auditory cue (80 dB,
5 kHz), the conditional stimulus, was presented for 20 s.
A 2-s foot shock (0.8 mA), the unconditional stimulus,
was administered after the termination of the tone. This
procedure was repeated with an interval of 100 s, and
the rats were removed from the chamber 30 s later.
Contextual assessment was performed 24 or 72 h after
surgery in the same chamber but with no cues (tone or
shock). Freezing behavior, recognized as lack of move-
ment, was recorded for 300 s by video and analyzed by
software (Xeye Fcs, Beijing MacroAmbition S&T Devel-
opment Co., Ltd., Beijing, China). A decrease in the per-
centage of time spent freezing indicated impairment of
memory.
Y maze test
The Y maze consisted of three arms (regions I–III, 30 ×
5 × 20 cm) that converged to an equilateral triangular
central area (region 0). Each arm had a lamp at the distal
end. A safe region was associated with the illumination,
whereas the other regions featured electrical foot stimu-
lation (40 ± 5 V). Each rat was first placed at the end of
one arm (starting area chosen randomly) and allowed to
move freely in the maze during a 3-min session without
any stimulation to adapt to the environment. The test
was then started and the illuminated arm (safe region)
served as the new starting area. Furthermore, we
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changed the orientation of the safe and stimulation re-
gions using a randomization method. The test was con-
sidered to be successful (learned) if the rat reached the
safe region within 10 s. After each foot stimulation, we
waited for the rat to reach the illuminated arm (the new
starting area) before the next stimulation. If nine re-
sponses were correct in ten consecutive foot stimula-
tions (9/10 standard), the rats were defined as having
reached the learning criterion. The total number of stim-
ulations to reach the criterion during training was re-
corded as the learning ability. All rats reached the
learning criterion in the present study.
In vitro studies
P815 cell culture
P815, a MCs line from mouse tumor cells, was provided
by FuNing, PhD, Department of Immunology, Southern
Medical University. The cells were incubated with
DMEM medium containing inactivated 10 % fetal bovine
serum and penicillin-streptomycin (0.6 × 105 μl−1) at 37 °
C and 5 % CO2 saturated humidity. The test was per-
formed when the cells were in the logarithmic phase of
growth.
Primary neuronal cultures
A pregnant C57BL/6 mouse (13–15 days) was killed by
decapitation, fetal ones were isolated from the womb as
previously described [23], and the skull was opened and
the brain removed. After removal of the meninges from
the whole brain, the regions of both hippocampus were
harvested. The isolated samples of distinct brain regions
were collected in separate Petri dishes in neurobasal
medium containing 0.02 % BSA and transferred for tis-
sue digestion into separate tubes containing the appro-
priate enzyme solutions. The issue was digested at 37 °C
for 15 min in 0.25 % trypsin (2.5 % trypsin solution from
Gibco was diluted 1:6 in PBS with EDTA). At the end of
digestion, the tissue samples were centrifuged (1500
r.p.m. 5 min), and the supernatants were carefully re-
moved. Cells were cultured with neurobasal medium
supplemented with 2 % B27 (Gibco), 1 % glutamine
100 × (Gibco) and antibiotics. After 5–6 days, neurons
with a better growth status were used in our study. The
proportion of neurons in these cell cultures was more
than 90 % as shown by immunohistochemistry using the
anti-NSE antibody.
Microglia-enriched cultures
Microglial cells were obtained from the brains of new-
born mice as described previously [24]. Briefly, mice
were decapitated, their brains were dissected, and the
meninges were carefully stripped off. Tissues were
mechanically dissociated and resuspended in DMEM
containing 10 % fetal calf serum, 100 U/ml penicillin,
and 100 mg/ml streptomycin. Cultures were maintained
at 37 °C in a humidified atmosphere of 5 % CO2/95 %
air. After reaching a confluent monolayer of glial cells
(10–14 days), microglia were separated from astrocytes
by shaking off at 100 r.p.m for 1 h and replated on 24-
well culture plates at a density of 105 cells/cm2. The
enriched microglia was >98 % pure as determined by
Iba1.
Co-culture of microglia and P815 cells
After treatment with Cromolyn for 30 min, the P815
cells (1 × 106 cells) were stimulated with lipopolysacchar-
ide (LPS) (1 μg/ml) and cultured for up to 48 h. Primary
microglia (1 × 106 cells) were grown in 5 cm × 5 cm
flasks until confluent and were treated with conditioned
medium from P815 cells with different treatments for
48 h, which were incubated for an additional 24 h.
Co-culture of P815 cells and primary neurons
After treatment with Cromolyn for 30 min, the P815
cells (1 × 106 cells) were stimulated with LPS (1 μg/ml)
and cultured for up to 48 h. Primary neurons (1 × 106
cells) were grown in 5 cm × 5 cm flasks until confluent
and were treated with conditioned medium from P815
cells with different treatment for 48 h, which were incu-
bated for an additional 24 h.
Immunofluorescence
To determine the activation of the microglia, the cells
were fixed with 4 % paraformaldehyde for 30 min; non-
specific binding was blocked by incubating cells in a 5 %
BSA (0.1 % Triton X-100) for 1 h at room temperature.
The microglial cells were incubated with rabbit anti-Iba1
monoclonal antibody (1:200), and neurons were incu-
bated with rabbit anti-Synapsin I antibody (SYP) (1:200)
and rabbit anti-PSD95 (1:500) antibody in the blocking
solution overnight at 4 °C. After three washes with PBS,
cells were incubated with the FITC-conjugated goat
anti-rabbit IgG (1:200) at 37 °C for 1 h and the nuclei
were stained with DAPI. Fluorescent images were ac-
quired using a confocal microscope.
PCR
Total RNA from the hippocampus and primary microglia
cell cultures was extracted with RNase (Takara), and reverse
transcription was performed from 1 μg of total RNA for
each sample using the Transcription First Strand cDNA
Synthesis Kits (Roche) according to the manufacturer’s in-
structions. Real-time PCR amplification was performed
using the STEP ONE Real-time PCR Detection System
(Foster City, CA) with the SYBR Green master mix (Ap-
plied Biosystems, Foster City, CA) in a final volume of
10 μl that contained 1 μl cDNA template from each sample.
Primers are listed as the following: rat CD86 forward,
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GACACCCACGGGATCAATTA reverse, AGGTTTCG
GGTATCCTTGCT; rat CD32 forward, AGTTCGTTGC
CGGTATTGAC reverse, TTCCCTGTGATCAGGGTTTC;
rat IL-1β forward, ACTATGGCAACTGTCCCTGAAC re-
verse, GTGCTTGGGTCCTCATCCTG; rat CD206 for-
ward, TGTGAGCAACCACTGGGTTA reverse, GTGCA
TGTTTGGTTTGCATC; rat SOCS3 forward, CCTCTG
AGGTTCAGGAGCAG reverse, CGTTGACAGTCTTCC-
GACAA; rat GAPGH forward, GGGTGTGAACCACGA-
GAAAT reverse, CCACAGTCTTCTGAGTGGCA; mouse
CD86 forward, GACCGTTGTGTGTGTTCTGG reverse,
GATGAGCAGCATCCAAGGA; mouse CD32 forward,
GAAACCCTGATCACAGGGAA reverse, TTTGGCA
GCTTCTTCCAGAT; mouse IL-1β forward, TTGACG-
GACCCCAAAAGAT reverse, GAAGCTGGATGCTCT-
CATCTG; mouse CD206 forward, CAAGGAAGGTT
GGCATTTGT reverse, CCTTTCAGTCCTTTGCAAGC;
mouse SOCS3 forward, TGCAGGAGAGCGGATTCTAC
reverse, TGACGCTCAACGTGAAGAAG; mouse GAPDH
forward, AACTTTGGCATTGTGGAAGG reverse, GGAT
GCAGGGATGATGTTCT. The cycling conditions were
95 °C for 30 s followed by 40 cycles of 95 °C for 5 s and
60 °C for 30 s. The relative mRNA values were normalized
to the GAPDH gene control values and calculated using
the comparative cycle threshold (ΔΔCt) method.
TNF-α and IL-6 assay
The content of tumor necrosis factor-α (TNF-α) and
interleukin-6 (IL-6) in rat hippocampus tissue extracts
and the amount of TNF-α and IL-6 in the culture
medium were measured with a commercial ELISA kit
from R&D Systems.
Western blotting
Ipsilateral hippocampus tissues, microglia cells, and neu-
rons were homogenized in RIPA lysis buffer (Biyuntian,
Shanghai, China), which contained 50 mM Tris
(pH 7.4), 150 mM NaCl, 1 % Triton X-100, 1 % sodium
deoxycholate, 0.1 % sodium dodecyl sulfate (SDS), so-
dium orthovanadate, sodium fluoride, EDTA, leupeptin,
etc. The homogenates were centrifuged at 12,000g for
20 min (4 °C), and the supernatants were then harvested
as cytosolic fractions for immune blot analysis. After in-
cubation for 20 min on ice, lysate was centrifuged and
protein concentration was determined by the BCA kit.
Proteins (50 μg) were denatured with SDS sample buffer
and separated by 10 % SDS-polyacrylamide gel electro-
phoresis. Proteins were transferred to PVDF membranes
(Millipore) by using a Bio-Rad miniprotein-III wet trans-
fer unit. The membranes were incubated with 5 % BSA
dissolved in Tris-buffered saline with Tween 20 (TBST)
(pH 7.5, 10 mM Tris–HCl, 150 mM NaCl, and 0.1 %
Tween 20) at room temperature for 1 h. This was
followed by incubating the membranes with different
antibodies overnight at 4 °C. The following primary anti-
bodies were used: rabbit monoclonal anti-c-Jun N-
terminal kinase (JNK), phospho-JNK, extracellular regu-
lated protein kinases (ERK), phospho-ERK, AKT,
phospho-AKT, Bax, Bcl-2 (1:1000), rabbit polyclonal
anti-SYP and PSD95, and mouse monoclonal anti-matrix
metalloproteinase-9 (MMP-9). After adding the goat-
anti-rabbit or goat-anti-mouse secondary antibody
(1:5000) for 1 h, the protein bands on the membranes
were detected with an enhanced chemiluminescence kit.
Transferase dUTP nick end labeling (TUNEL) assay
Terminal deoxynucleotidyl TUNEL assay, a method for
detecting DNA fragmentation, was used to measure
neuronal apoptosis. The one-step TUNEL apoptosis
assay kit is obtained from KeyGEN BioTECH
(KGA7074). In brief, after respective treatment, cells
plated on slides were fixed with 4 % formaldehyde for
30 min in room temperature. After washed three times
by PBS, slides were incubated with 1 % Triton X-100 for
5 min and then incubated with FITC-conjunctive
fluorescein-12-dUTP for 30 min in 37 °C. The nuclei
were stained with DAPI. Fluorescent images were ac-
quired using a confocal microscope.
Statistical analysis
All values are means ± SD. The significance of the differ-
ence between control and samples treated with various
drugs was determined by one-way ANOVA followed by
the post hoc least significant difference test. Differences
were considered significant at P < 0.05.
Results
1. Cromolyn inhibited surgery-induced MCs degranu-
lation in the hippocampus
To examine whether MCs are involved in surgery-
induced neuroinflammation, we first quantified brain
MCs in toluidine blue (TB) and MC tryptase stained
sections of the hippocampus at 1 and 3 days after
surgery. As shown in Fig. 1a, b, surgery led to a sig-
nificant increase in MCs number in area CA1 of the
hippocampus and was significantly greater than the
counts in the control group at 1 and 3 days after
surgery. This effect was inhibited by directed site in-
jection in the right ICV of MC stabilizer Cromolyn
(200 μg, 2.5 μl). In addition, directed site injection of
the mast cell degranulator C48/80 (2.5 μg) alone also
promoted the increasing number of MCs obviously
at 1 day, similar to the effect induced by surgery.
Furthermore, site injection of C48/80 (2.5 μg)
30 min before surgery caused a synergistic increase
in the number of MCs in the hippocampus. And site
injection of Cromolyn (200 μg) alone had no effect
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on MCs in the brain. These results suggest that
surgery can induce MC degranulation in the
hippocampus.
2. Cromolyn inhibited microglia activation in the
hippocampus induced by the tibial surgery
In order to explore the effects of activated MCs on
microglia activation, immunostaining was used to
detect Iba1, a marker for microglia. Surgery led to
notable increases in microglia activation in the
hippocampus at 1 and 3 days, as indicated by a large
number of Iba1-ir cells, which had larger cell body,
and poorly ramified short and thick processes
(Fig. 2a, b). The effect could once again be prevented
through pretreatment with a MC stabilizer and
aggravated by pretreatment with a MC degranulator.
Treatment with the MC degranulator once again led
to a similar readout as surgery. To further observe
the effect of activated MCs on phenotype change of
microglia in the hippocampus, the phenotype
markers of microglia in area CA1 of the hippocam-
pus at 1 day were tested. Surgery increased the
expression of M1 markers (CD86, CD32, IL-1β) and
immunomodulatory M2b marker (SOCS3) caused a
decrease in the expression of M2a-repair/regener-
ation marker (CD206), which instead of the activa-
tion of microglia (Fig. 2c–g). These results suggest
that stabilization of MC can inhibit the activation of
microglia.
3. Cromolyn inhibited surgery-induced and neuronal
apoptosis in the hippocampus and ameliorated the
cognitive decline
To further confirm whether activated mast cells
participate in cognitive dysfunction, we tested for
neuronal apoptosis with caspase-3 immunostaining
and assessed learning and memory with behavioral
tests. To further examine neuronal injury, we then
explored the expression levels of amyloid precursor
protein (APP), PSD95, and Bax/Bcl-2. Surgery could
induce dramatic increases in caspase-3 expression in
the hippocampus at 1 and 3 days postoperation, and
Cromolyn (200 μg) capably protected against neur-
onal injury, with the same response with APP,
Fig. 1 Cromolyn inhibited surgery-induced MC degranulation in the hippocampus. a Immunostaining was used to detect mast cell tryptase in
area CA1 of the hippocampus. Scale bar 50 μm. b Mast cells were stained with toluidine blue (TB) in area CA1 of the hippocampus. Scale bar
50 μm. c Quantification of Tryptase-positive cells in area CA1 of the hippocampus. d Quantification of mast cells stained with TB. *P < 0.05,
**P < 0.01 vs. control group. #P < 0.05, ##P < 0.01 vs. surgery group. Data are presented as the mean ± SD (n = 6)
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PSD95, and Bax/Bcl-2 expression (Fig. 3a, b, e, and
f ). Meanwhile, injection of Cromolyn alone did not
change the freezing time and number of learning tri-
als. However, compared against controls, the rats ex-
posed to surgery exhibited a significant reduction in
cognitive function at 1 and 3 days. Notably, treat-
ment with Cromolyn significantly improved the
freezing behavior and the number of learning trials
at 1 and 3 days (Fig. 3c, d). These results suggest
that Cromolyn may help protect against surgery-
induced cognitive dysfunction.
4. Cromolyn inhibited surgery-induced mitogen-
activated protein kinase (MAPK) activation and cy-
tokines secretion in the hippocampus
Since microglia-mediated neuroinflammation is
mainly due to the excessive secretion of proinflam-
matory factors from activated microglia and their
downstream signaling cascades, the levels of proin-
flammatory factors TNF-α and IL-6 were detected
by ELISA. Surgery induced significant increases in
TNF-α and IL-6 production, and site injection of
Cromolyn (200 μg) could inhibit the inflammatory
response (Fig. 4c, d). To confirm the signaling path-
ways involved in neuroinflammation, MAPK-related
proteins were tested with Western blot. Surgery led
to the rapid phosphorylation of ERK and JNK in the
hippocampus, a change that can be prevented by
Cromolyn (200 μg) pretreatment (Fig. 4a, b). In
addition, site injection of Cromolyn (200 μg) alone
had no effect on cytokine production in the hippo-
campus. Furthermore, pretreatment with C48/80
(2.5 μg) could exacerbate the inflammatory response
of CNS induced by surgery. These results suggest
that stabilization of MCs can inhibit the production
of proinflammatory factors in the hippocampus, and
MAPK signaling pathways were involved.
5. Activated P815 cells increased microglia activation
Given that our previous results clearly indicate a
correlation between MCs and neuroinflammation
caused by surgery, we then sought to clarify the
Fig. 2 Cromolyn inhibited microglia activation in the hippocampus induced by the tibial surgery. a Immunostaining was used to detect Iba1 in
area CA1 of the hippocampus, markers for microglia. Scale bar 50 μm. b Quantification of Iba1-positive cells in area CA1 of the hippocampus. c–e
Expression levels of M1 phenotype markers (CD86, CD32, and IL-1β). f Expression levels of CD206, markers for M2a phenotype. g Expression levels
of SOCS3, markers for M2b phenotype. *P < 0.05, **P < 0.01 vs. control group. #P < 0.05, ##P < 0.01 vs. surgery group. Data are presented as the
mean ± SD (n = 6)
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importance of this correlation. Since microglia
activation is an early sign that triggers neuronal
death in neurodegenerative disorders, we explored
the effect of activated MCs on microglia in vitro.
Microglia activation was detected via
immunofluorescent staining for Iba1. The transfer of
medium from P815 cells stimulated with LPS could
induce a significant increase in microglia activation,
an effect inhibited by the additional treatment of
cromolyn. With the same effect of LPS (1 μg/ml)
alone, incubated with CM from P815 with LPS-
stimulation (48 h) for 24 h could induce microglia
activation obviously. Pretreatment with Cromolyn
(10 μg/ml) for 30 min suspended the activated effect
of MCs on microglia (Fig. 5a). To further confirm
the effect of P815 on phenotype change of primary
microglia, the phenotype markers of microglia were
tested. LPS (1 μg/ml) increased the expression of
M1 markers (CD86, CD32, IL-1β) and immunomod-
ulatory M2b marker(SOCS3), caused a decrease in
the expression of M2a-repair/regeneration marker
(CD206) [25], both directly and through P815 cells.
Fig. 3 Cromolyn inhibited surgery-induced and neuronal apoptosis in the hippocampus and ameliorated the cognitive decline. a Immunostaining
was used to detect caspase-3 in area CA1 of the hippocampus. Scale bar 50 μm. b Quantification of caspase-3-positive cells in area CA1 of the
hippocampus (n = 6). The freezing time in trace fear conditioning test (c) and the number of learning trials in Y Maze test (d) were recorded to
analyze the cognitive changes (n = 10). e The expression of Bax, Bcl-2, APP, PSD95, and MMP-9 was detected by Western blotting using specific
antibodies in the hippocampus of rats. Each blot is representative of three experiments. f Expression of Bax was quantified and normalized to
Bcl-2 levels, and expression of APP, PSD95, and MMP-9 were quantified and normalized to GAPDH levels. Each value was then expressed relative
to the control, which was set to 1 (n = 5). *P < 0.05, **P < 0.01 vs. control group. #P < 0.05, ##P < 0.01 vs. surgery group. Data are presented as
the mean ± SD
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Pretreatment with Cromolyn (10 μg/ml) for 30 min
can inhibit microglia activation effectively (Fig. 5b–f ).
These results indicated that activated secreted prod-
ucts from P815 could induce microglia activation and
change the phenotypes of microglia towards M1/2b.
6. MAPK signaling pathways were involved in
microglia activation and cytokine production
Since changes in MAPK signaling pathways were
observed in the MC-induced microglia activation in
vivo, we then investigated these signaling pathways in
vitro for further verification. LPS stimulation (48 h) of
microglia in vitro stimulated a higher phosphorylation
of ERK and JNK, which was ameliorated by Cromolyn
(10 μg/ml) pretreatment (Fig. 6a, b). To observe the
inflammatory effects of MC microglia co-culture, pro-
inflammatory factors TNF-α and IL-6 in the super-
natant were detected with ELISA. As shown in
Fig. 6c, d, with the same effect of LPS alone, cytokine
production was also sharply upregulated by CM from
P815 with LPS stimulation, and P815 with Cromolyn
(10 μg/ml) pretreatment could improve the inflamma-
tory response. Collectively from this data, we con-
cluded that MAPK signaling pathways were involved
in MC-induced microglia activation.
7. Activated P815 cells induced neuronal apoptosis
To explore the direct effect of activated MCs on
neurons, we tested neuronal apoptosis and synaptic
changes. With the same effect of LPS (1 μg/ml)
alone, incubated with CM from P815 with LPS,
stimulation (48 h) for 24 h could induce neuronal
loss. Results from TUNEL test showed that CM
from P815 with LPS stimulation could induce
neuronal apoptosis (Fig. 7a), presented with the SYP
and PSD95 changes (Fig. 7b–d). The above results
indicated that activated MCs could induce neuronal
apoptosis directly.
Discussion
Pathological mechanisms that regulate neuroinflamma-
tion have not been well characterized, even though
Fig. 4 Cromolyn inhibited surgery-induced MAPK activation and cytokine secretion in the hippocampus. a The activated levels of ERK and JNK in the
area CA1 of the hippocampus, which was assessed by increased phosphorylation of tyrosine residues of these kinases, were detected by Western
blotting using specific antibodies. Each blot is representative of three experiments. b Phosphorylated levels of ERK and JNK were quantified and
normalized to total levels. Each value was then expressed relative to the control, which was set to 1. c–d The levels of proinflammatory factors TNF-α
and IL-6 were detected by ELISA. *P < 0.05, **P < 0.01 vs. control group. #P < 0.05, ##P < 0.01 vs. surgery group. Data are presented as the
mean ± SD (n = 5)
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neuroinflammation may provoke many clinically import-
ant phenomena, such as the occurrence and develop-
ment of cognitive dysfunction after peripheral surgery.
Previous authors have raised the concern that important
therapeutic targets against neuorinflammation were be-
ing missed by exploring microglia and MCs in isolation
from each other [18]. In this study, we explored the ef-
fect of MCs on microglia activation and its role in
POCD. We demonstrate that activated brain MCs are
able to activate microglia and induce neuronal apoptosis,
aggravating neuroinflammation. We show that this
activation can occur as a result of peripheral surgery and
that cognitive function strongly correlates with MC
activation.
Cognitive dysfunction after peripheral surgery,
whether in the form of temporary delirium or POCD,
has been associated with long-term adverse outcomes
including low quality of life, heavier burden of economy,
and an increasing mortality rate [26, 27]. In rodents,
POCD symptoms can be modeled with deficits in ex-
ploratory behavior and spatial-based working memory.
TFC is widely used to assess learning and memory in
Fig. 5 Activated P815 cells increased microglia activation. a The cells were stained with Iba1 antibody, and upregulated Iba1-immunopositive
expression (green) on the activated microglia was observed using confocal scanning. The blue staining represents DAPI. Scale bar 50 μm was used
to detect Iba1. b–d Expression levels of M1 phenotype markers (CD86, CD32, and IL-1β). e Expression levels of CD206, markers for M2a
phenotype. f Expression levels of SOCS3, markers for M2b phenotype. *P < 0.05, **P < 0.01 vs. control group. #P < 0.05, ##P < 0.01 vs. CM (P815 lps)
group. Data are presented as the mean ± SD (n = 5)
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rodents [28]. In the present study, we found that predir-
ected site injection in the right ICV with MC stabilizer
Cromolyn improved learning and memory of SD rats by
increasing the rate of freezing time both 1 and 3 days
after the tibial surgery. Directed site injection of C48/80
alone, which is MC degranulator, could also induce cog-
nitive deficiency, as the same effect with peripheral sur-
gery at 1 day after surgery. These results were then
confirmed via the Y maze test, one of the most widely
used paradigms for detecting spatial-based working
memory in rodents [29]. It is very sensitive for measuring
early-onset postoperative cognitive deficit and is usually
used to assess hippocampus-dependent working memory
[30, 31]. Meanwhile, hippocampal neurogenesis-related
cognition is found to decline by using electric shocks Y
maze [32]. In our study, we also used this type of Y maze
test to evaluate the spatial-based working memory 1 and
3 days after the tibial fracture surgery, and the assessment
was approximately the same as TFC. Thus, we considered
that activated MCs may participate in the cognitive defi-
ciency after the tibial surgery. The study by Nautiyal et al.
implicates brain mast cells in the modulation of anxiety-
like behavior and provides evidence for the behavioral im-
portance of neuroimmune links [33]. Approximately one
third of patients with mastocytosis display neuropsycho-
logical symptoms [34]. Masitinib, an inhibitor of the sur-
vival, migration, and activity of MCs, can improve the
cognitive decline in ADs [35]. All of those showed the re-
lationship between MCs and cognitive decline.
Inflammation is fundamentally protective in restor-
ing injury and initiating the healing process, but de-
structive when prolonged to override the bounds of
physiological. Increasing evidence recognize neuroin-
flammation as a key element in the pathobiology of
neurodegenerative diseases [36–38]. As the sensor
cells for disturbed brain tissue homeostasis, particu-
larly in response to neuron injury, microglia cells re-
lease proinflammatory molecules that play key roles
in neurodegenerative diseases [39]. Activation of
microglia has been demonstrated to be an early sign
that often precedes and triggers neuroinflammation and
neuronal death in neurodegenerative diseases [40, 41].
Our previous studies found that microglia activation par-
ticipate in the surgery-induced neuroinflammation and
cognitive decline through TLR4/MyD88 signaling, which
can be improved by preintraperitoneal injection of lithium
for continuous 6 days before splenectomy [42]. As the
similar results shown in this study, microglia cells were ac-
tivated significantly in surgery group after the tibial sur-
gery. At the same time, it also showed with neuronal
apoptosis and cytokine secretion simultaneously in CA1
region of the hippocampus. MAPK signaling pathway,
which is an important regulator of inflammation, was in-
volved. Microglia cells mediate multiple facets of neuroin-
flammation, including cytotoxicity, repair, regeneration,
and immunosuppression and have the ability to acquire
diverse activation states or phenotypes [25]. We found
that surgery increased expression of cytotoxic M1
markers (CD86, CD32, and IL-1β) and immunomodu-
latory M2b markers (SOCS3). Meanwhile, surgery
caused a decrease in the expression of M2a-repair/re-
generation markers (CD206). Within the aged brain,
microglia cells are primed and easily produce a more
violent response to inflammatory stimulation [43].
Fig. 6 MAPK signaling pathways were involved in microglia activation and the following cytokine production. a The activated levels of ERK and
JNK, which was assessed by increased phosphorylation of tyrosine residues of these kinases, was detected by Western blotting using specific
antibodies. Each blot is representative of three experiments. b Phosphorylated levels of ERK and JNK were quantified and normalized to total
levels. Each value was then expressed relative to the control, which was set to 1. c–d The levels of proinflammatory factors TNF-α and IL-6 were
detected by ELISA. *P < 0.05, **P < 0.01 vs. control group. #P < 0.05, ##P < 0.01 vs. CM (P815 lps) group. Data are presented as the mean ± SD (n = 5)
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Microgliosis, which is defined as an increased number
of microglia, is an important response of neuroinflam-
mation [8]. Therefore, the inhibition of microglial
activation may offer prospective clinical therapeutic
benefits for neuroinflammation-related neurodegenera-
tive disorders.
Fig. 7 Activated P815 cells induced neuronal apoptosis directly. a Neuronal apoptosis was tested with TUNEL test. b The cells were stained with
SYP and PSD95 antibody and upregulated SYP, and PSD95-immunopositive expression (green) on the activated microglia was observed using
confocal scanning, respectively. The blue staining represents DAPI. Scale bar 50 μm was used to detect Iba1. c The expression of Bax, Bcl-2, SYP,
and PSD95 was detected by Western blotting using specific antibodies in the hippocampus of rats. Each blot is representative of three
experiments. d Expression of Bax was quantified and normalized to Bcl-2 levels. Expression of SYP and PSD95 were quantified and normalized to
GAPDH levels. Each value was then expressed relative to the control, which was set to 1. *P < 0.05, **P < 0.01 vs. control group. #P < 0.05,
##P < 0.01 vs. CM (P815 lps) group. Data are presented as the mean ± SD (n = 5)
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Prototypical proinflammatory stimuli (LPS, IL-1β, and
TNFa) have been shown to increase microglia activation
and cytokine production [25]. However, the factors con-
tribute to the overactivation of microglia are still largely
covered. Notably, microglia cells also respond to proin-
flammatory substances released from other immune cells
such as MCs. The corresponding receptors of tryptase
and histamine have been found on the surface of micro-
glia in our previous studies [14, 15]. MCs are found in
most tissues, including CNS, where they are often found
adjacent to blood vessels and nerves [44] and can
traverse the blood-brain barriers in pathological condi-
tions [45]. Emerging evidence of MCs-microglia inter-
action opens new insights for therapies targeting
neuroinflammation by modulating activation of MCs
that may control the overactivation of microglia. Jin et
al. demonstrated that MC activation is the “first re-
sponder” in this type of injury, preceding microglia acti-
vation [46]. Consistent with it, in the present vivo study,
we found that surgery could activate not only MCs but
also microglia at 1 but 3 days that was ameliorated by
Cromolyn. The study by Schemann et al. demonstrated
that the MC degranulator C48/80 may directly activate
neurons, which can be preserved by histamine H1 and
H2 antagonists [47]. To further ensure the effect of MCs
on microglia directly, we co-cultured P815 cells and pri-
mary microglia in vitro. We found that LPS-stimulated
P815 cells can activate microglia and induce TNF-α and
IL-6 release. Pretreatment with “Mast cell stabilizer”
Cromolyn (10 μg/ml) for 30 min could inhibit the
phenomenon. However, the P815 cells without LPS
stimulation had no effect on microglia activation. MAPK
signaling pathway was involved. These results further
confirm that activated MCs can induce microglia activa-
tion and cytokine release.
Although the functional relationship between MCs
and neurons in CNS is not yet well clarified, communi-
cation between MCs and peripheral nerves has been ex-
amined and may be helpful to inform CNS roles [48].
Cell adhesion molecule-1d expressed by mature hippo-
campal neurons also is found to be the isoform that
MCs most strongly adhere to in vitro, as part of a direct,
contact-based signaling [49]. Mediators released from
MCs, like nerve growth factor and ATP, are required for
neuronal survival and physical function [50, 51]. All the
above reveal the close communication between MCs
and neurons, which may be a fundamental element for
the physical neuronal function. But in pathological con-
ditions, whether degranulation of MCs can result in
neuronal apoptosis is still unknown. In the present vivo
study, we found that the activation of MCs can induce
neuronal apoptosis and neuro-synapsis injury. To elim-
inate the effect of microglia, we co-cultured P815 cells
and primary neuron in vitro in order to ensure that the
effect was indeed a direct one. The results revealed that
activated MCs can induce neuronal apoptosis directly,
without microglia intermediaries. We therefore antici-
pate that surgery-induced MC degranulation can result
in hippocampal neuronal damage both via, and inde-
pendent of, microglia activation.
Conclusions
In summary, the present study identifies that peripheral
surgery induce MCs degranulation, following by micro-
glia activation and neuronal apoptosis, resulting in neu-
roinflammation and cognitive dysfunction, which can be
inhibited by the “MCs stabilizer” Cromolyn. In vitro
study further confirms that only the activated MCs can
induce microglia activation, and MAPK pathways are in-
volved. In addition, activated MCs could directly induce
neuronal apoptosis with microglia independently These
results implicate that activated MCs could not only trig-
ger microglia activation but also induce neuronal dam-
age directly, resulting in neuroinflammation, and
interactions between MCs, microglia, and neuron could
constitute a new and unique therapeutic target for
neuroinflammation-related diseases.
Highlights
 Surgery can induce mast cells degranulation,
microglia activation, and neuronal apoptosis.
 “Mast cell stabilizer” Cromolyn can inhibit surgery-
induced microglia activation and neuronal apoptosis.
 Activated mast cells can evoke microglia activation
and neuroinflammation.
 Activated mast cells can induce neuronal apoptosis
directly.
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